SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ryan, J.
Right arrow Articles by Stough, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, J.
Right arrow Articles by Stough, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population

J. Ryan

National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia

K. Croft

School of Medicine and Pharmacology, University of Western, Perth, Australia

T. Mori

School of Medicine and Pharmacology, University of Western, Perth, Australia

K. Wesnes

Cognitive Drug Research Ltd, Goring-on-Thames UK

J. Spong

National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia

L. Downey

National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia

C. Kure

National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia

J. Lloyd

National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia

C. Stough

National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia, cstough{at}swin.edu.au

The study examines the effects of the antioxidant flavonoid Pycnogenol on a range of cognitive and biochemical measures in healthy elderly individuals. The study used a double-blind, placebo-controlled, matched-pair design, with 101 elderly participants (60—85 years) consuming a daily dose of 150 mg of Pycnogenol for a three-month treatment period. Participants were assessed at baseline, then at 1, 2, and 3 months of the treatment. The control (placebo) and Pycnogenol groups were matched by age, sex, body mass index, micronutrient intake, and intelligence. The cognitive tasks comprised measures of attention, working memory, episodic memory, and psychomotor performance. The biological measures comprised levels of clinical hepatic enzymes, serum lipid profile, human growth hormone, and lipid peroxidation products. Statistically significant interactions were found for memory-based cognitive variables and lipid peroxidation products, with the Pycnogenol group displaying improved working memory and decreased concentrations of F2-isoprostanes relative to the control group.

Key Words: antioxidant • aged • cognition • oxidative stress • Pycnogenol

Journal of Psychopharmacology, Vol. 22, No. 5, 553-562 (2008)
DOI: 10.1177/0269881108091584


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
M. R. Cesarone, G. Belcaro, S. Stuard, F. Schonlau, A. Di Renzo, M. G. Grossi, M. Dugall, U. Cornelli, M. Cacchio, G. Gizzi, et al.
Kidney Flow and Function in Hypertension: Protective Effects of Pycnogenol in Hypertensive Participants--A Controlled Study
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2010; 15(1): 41 - 46.
[Abstract] [PDF]



Advertisement